XNAS
ZTEK
Market cap51mUSD
Jul 09, Last price
0.47USD
1D
-1.85%
1Q
-13.86%
Jan 2017
-26.18%
IPO
45.82%
Name
Zentek Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zentek Ltd. is a Canadian company focused on the exploration and advancement of graphene and related nanomaterials. It fully owns the Albany Graphite project, situated in Northern Ontario, Canada. The firm develops its ZenGUARD brand, a graphene-based antimicrobial coating, incorporating it into products like surgical masks, HVAC filters, and personal protective equipment. Additionally, Zentek's innovation extends to rapid detection point-of-care diagnostics and pharmaceutical products, all leveraging graphene-based compounds. The company also specializes in synthesizing graphene, graphene oxide, and graphene quantum dots for diverse applications. Founded in 2008 and headquartered in Thunder Bay, Canada, Zentek Ltd. was formerly known as ZEN Graphene Solutions Ltd. until its name change in October 2021.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||